Study Title: A Study to Evaluate Efficacy and Safety of BMS-986165 in Adults With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) - IM011-132 Sponsor Name: Bristol-Myers Squibb (BMS) Purpose of Study: The purpose of this study is to see if a study medication…
In a recent international survey, the World Lupus Federation found that 87% of the survey respondents living with lupus reported that the disease has impacted one or more major organs or organ systems. Over 6,700 people with lupus participated in the survey from over 100 countries.
Check out some highlights from another successful World Lupus Day in 2022!
Take part in a global effort for people with lupus and share your experience with the disease.
Lupus often causes severe pain and overwhelming fatigue that interferes with activities of daily living. Isolation and depression resulting from lupus can be devastating. The emotional impact of lupus can be as devastating as the physical symptoms.
A new study concludes that hydroxychloroquine therapy is safe for long-term use at doses <5 mg/kg/day.
The strategy this year was to focus on the physical, economic, social and psychological burdens of lupus.